ABVC BioPharma (ABVC) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

ABVC BioPharma Revenue Highlights


Latest Revenue (Y)

$152.43K

Latest Revenue (Q)

$117.14K

ABVC BioPharma Revenue by Period


ABVC BioPharma Revenue by Year

DateRevenueChange
2023-12-31$152.43K-84.28%
2022-12-31$969.78K172.57%
2021-12-31$355.80K-26.34%
2020-12-31$483.05K-31.16%
2019-12-31$701.72K9987.97%
2018-12-31$6.96K117.65%
2017-12-31$3.20K9887.50%
2016-09-30$32.00-99.05%
2015-09-30$3.36K100.00%
2014-09-30--100.00%
2013-09-30$7.79K36.28%
2012-09-30$5.71K79.12%
2011-09-30$3.19K-78.53%
2010-09-30$14.86K100.00%
2009-09-30--100.00%
2008-09-30$25.09K-39.78%
2007-09-30$41.67K100.00%
2006-12-31-100.00%
2005-12-31--100.00%
2004-12-31$57.49K320.59%
2003-12-31$13.67K36.70%
2002-12-31$10.00K-

ABVC BioPharma generated $152.43K in revenue during NA 2023, up -84.28% compared to the previous quarter, and up 2191.35% compared to the same period a year ago.

ABVC BioPharma Revenue by Quarter

DateRevenueChange
2024-06-30$117.14K9621.33%
2024-03-31$1.21K-44.34%
2023-12-31$2.17K-86.37%
2023-09-30$15.88K160.01%
2023-06-30$6.11K-95.24%
2023-03-31$128.27K-78.22%
2022-12-31$588.99K1293.44%
2022-09-30$42.27K-86.49%
2022-06-30$312.86K1119.25%
2022-03-31$25.66K-167.90%
2021-12-31$-37.79K-138.18%
2021-09-30$99.00K214.87%
2021-06-30$31.44K-88.05%
2021-03-31$263.15K323.12%
2020-12-31$62.19K-46.18%
2020-09-30$115.55K-48.99%
2020-06-30$226.51K187.50%
2020-03-31$78.79K-21.18%
2019-12-31$99.96K-49.45%
2019-09-30$197.73K3.10%
2019-06-30$191.78K-9.64%
2019-03-31$212.24K7022.21%
2018-12-31$2.98K298.93%
2018-09-30$747.00-76.87%
2018-06-30$3.23K100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$70.00K100.00%
2016-09-30-100.00%
2016-06-30--100.00%
2016-03-31$32.00100.00%
2015-12-31--100.00%
2015-09-30$1.10K100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30--100.00%
2013-03-31$761.00-89.17%
2012-12-31$7.03K100.00%
2012-09-30-100.00%
2012-05-14--100.00%
2012-02-20$3.67K78.87%
2011-12-15$2.05K100.00%
2011-08-03-100.00%
2011-06-30--100.00%
2011-02-13$720.00-70.85%
2011-01-12$2.47K115.53%
2010-08-15$1.15K-59.49%
2010-06-30$2.83K-47.88%
2010-03-31$5.43K100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31--100.00%
2008-12-31$5.46K2523.56%
2008-09-30$208.00-94.86%
2008-06-30$4.05K-61.12%
2008-03-31$10.42K-

ABVC BioPharma generated $117.14K in revenue during Q2 2024, up 9621.33% compared to the previous quarter, and up 91.32% compared to the same period a year ago.

ABVC BioPharma Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SABSSAB Biotherapeutics$2.24M$263.14K
NTRBNutriband$2.09M$442.83K
LGVNLongeveron$709.00K$548.00K
ADTXAditxt$645.18K$44.28K
MGTADianthus Therapeutics$314.00K$72.00K
ABVCABVC BioPharma$152.43K$117.14K
VRAXVirax Biolabs Group$8.56K$76.50K
ANEBAnebulo Pharmaceuticals--
APTXAptinyx--
FBRXForte Biosciences--
EVLOEvelo Biosciences--
ALRNAileron Therapeutics--
AKTXAkari Therapeutics--
ARDSAridis Pharmaceuticals-$417.00K
RNXTRenovoRx--
MNPRMonopar Therapeutics--
INDPIndaptus Therapeutics--
QNRXQuoin Pharmaceuticals--
ELDNEledon Pharmaceuticals--
KTTAPasithea Therapeutics--
ACSTAcasti Pharma--

ABVC Revenue FAQ


ABVC BioPharma's yearly revenue for 2023 was $152.43K, representing a decrease of -84.28% compared to 2022. The company's yearly revenue for 2022 was $969.78K, representing an increase of 172.57% compared to 2021. ABVC's yearly revenue for 2021 was $355.8K, representing a decrease of -26.34% compared to 2020.

ABVC BioPharma's quarterly revenue for Q2 2024 was $117.14K, a 9621.33% increase from the previous quarter (Q1 2024), and a 1817.53% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.2K, a -44.34% decrease from the previous quarter (Q4 2023), and a -99.06% decrease year-over-year (Q1 2023). ABVC's quarterly revenue for Q4 2023 was $2.16K, a -86.37% decrease from the previous quarter (Q3 2023), and a -99.63% decrease year-over-year (Q4 2022).

ABVC BioPharma's revenue growth rate for the last 3 years (2021-2023) was -57.16%, and for the last 5 years (2019-2023) was -78.28%.